OBJECTIVE: Weight gain and bone loss are commonly reported in breast cancer survivors. The purpose of this pilot study is to assess feasibility and explore the effect of an aerobic weight-loaded exercise intervention on bone remodeling, weight, and body composition. DESIGN: A one-group pre-posttest design was used to test a 16-24-week supervised walking exercise intervention among women within 2 years of menopause. Through Weeks 1-4, time and weight were progressively increased. By Week 5 and through the end of the intervention, a waist belt was loaded with 5 lb and participants spent 45 min on the treadmill 3 times/week. Bone remodeling was measured by serum biomarkers (N-terminal propeptides of type I collagen [NTX] and serum osteocalcin). Dual-energy absorptiometry scans assessed body composition. Data were collected at baseline and 16 and 24 weeks. RESULTS: The majority of the 26 participants were married, well educated, and employed, with a mean age of 51.3 years (SD = 6.2). The high adherence (M = 88.2%, SD = 6.8) demonstrated feasibility. There were no significant changes in serum osteocalcin (p = .67), serum NTX (p = .31), lean muscle mass (p = .08), or percent fat mass for the group as a whole (p = .14), but fat mass increased for women on adjuvant endocrine therapy (p = .04). The women maintained their weight. CONCLUSIONS: This novel exercise intervention for breast cancer survivors was feasible, and women otherwise at high risk for weight gain and bone loss maintained their weight and bone mass.
OBJECTIVE:Weight gain and bone loss are commonly reported in breast cancer survivors. The purpose of this pilot study is to assess feasibility and explore the effect of an aerobic weight-loaded exercise intervention on bone remodeling, weight, and body composition. DESIGN: A one-group pre-posttest design was used to test a 16-24-week supervised walking exercise intervention among women within 2 years of menopause. Through Weeks 1-4, time and weight were progressively increased. By Week 5 and through the end of the intervention, a waist belt was loaded with 5 lb and participants spent 45 min on the treadmill 3 times/week. Bone remodeling was measured by serum biomarkers (N-terminal propeptides of type I collagen [NTX] and serum osteocalcin). Dual-energy absorptiometry scans assessed body composition. Data were collected at baseline and 16 and 24 weeks. RESULTS: The majority of the 26 participants were married, well educated, and employed, with a mean age of 51.3 years (SD = 6.2). The high adherence (M = 88.2%, SD = 6.8) demonstrated feasibility. There were no significant changes in serum osteocalcin (p = .67), serum NTX (p = .31), lean muscle mass (p = .08), or percent fat mass for the group as a whole (p = .14), but fat mass increased for women on adjuvant endocrine therapy (p = .04). The women maintained their weight. CONCLUSIONS: This novel exercise intervention for breast cancer survivors was feasible, and women otherwise at high risk for weight gain and bone loss maintained their weight and bone mass.
Authors: W Demark-Wahnefried; B L Peterson; E P Winer; L Marks; N Aziz; P K Marcom; K Blackwell; B K Rimer Journal: J Clin Oncol Date: 2001-05-01 Impact factor: 44.544
Authors: A-M Foucaut; S E Berthouze-Aranda; M Touillaud; A-S Kempf-Lépine; C Baudinet; R Meyrand; J Carretier; P Bachmann; B Fervers Journal: Support Care Cancer Date: 2013-12-03 Impact factor: 3.603
Authors: Melinda L Irwin; Marty Alvarez-Reeves; Lisa Cadmus; Eileen Mierzejewski; Susan T Mayne; Herbert Yu; Gina G Chung; Beth Jones; M Tish Knobf; Loretta DiPietro Journal: Obesity (Silver Spring) Date: 2009-02-19 Impact factor: 5.002
Authors: Christina M Dieli-Conwright; Joanne E Mortimer; E Todd Schroeder; Kerry Courneya; Wendy Demark-Wahnefried; Thomas A Buchanan; Debu Tripathy; Leslie Bernstein Journal: BMC Cancer Date: 2014-04-03 Impact factor: 4.430
Authors: Laura D Bilek; Nancy L Waltman; Joan M Lappe; Kevin A Kupzyk; Lynn R Mack; Diane M Cullen; Kris Berg; Meghan Langel; Melissa Meisinger; Ashlee Portelli-Trinidad; Molly Lang Journal: BMC Womens Health Date: 2016-08-30 Impact factor: 2.809